지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis
Toxicological Research
2017 .10
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Gut and Liver
2016 .01
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Clinical and Molecular Hepatology
2017 .01
Overview of anti-Hepatitis B virus agents
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2020 .09
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Clinical and Molecular Hepatology
2016 .01
Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
Gut and Liver
2016 .01
Efficacy of entecavir verses lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with allogeneic stem cell transplant
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Response to A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1
Infection and Chemotherapy
2024 .03
Unmet need in chronic hepatitis B management
Clinical and Molecular Hepatology
2019 .01
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
Gut and Liver
2016 .01
Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine- Resistant Chronic Hepatitis B
Gut and Liver
2015 .01
Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study
Journal of Korean Medical Science
2021 .01
Impact of Lamivudine Experience on the Antiviral Efficacy and Resistance Development of Entecavir in Chronic Hepatitis B Patients
Clinical and Molecular Hepatology
2015 .01
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Clinical and Molecular Hepatology
2016 .01
Management of Antiviral Resistance in Chronic Hepatitis B
Gut and Liver
2017 .01
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Clinical and Molecular Hepatology
2015 .01
만성 C형간염 치료의 최신 지견
대한내과학회지
2017 .01
Hepatitis C Virus and Antiviral Drug Resistance
Gut and Liver
2016 .01
국내 만성 B형 간염 환자의 경구용 항바이러스제 사용 현황 분석
한국임상약학회지
2016 .01
Immunotherapy for Chronic Hepatitis B Virus Infection
Gut and Liver
2018 .01
0